“miRNA-486 and miRNA-499 in human plasma evaluate the clinical stages of lung cancer and play a role as a tumor suppressor in lung tumorigeneisis not pathogenesis” (2016) Bangladesh Journal of Pharmacology, 11(1), pp. 264–268. doi:10.3329/bjp.v11i1.25318.